Trials / Unknown
UnknownNCT04889365
COVID-19 Antigen Rapid Test Kit
The Use of SG Diagnostics COVID-19 Antigen Rapid Test Kit for Self-testing as a Method for Reduction SARS-CoV-2
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Polish Society of Disaster Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The SG Diagnostics COVID-19 Antigen Rapid Test Kit (Colloidal Gold-Based) is a single-use test kit intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is intended for use with self-collected nasal swab samples in individuals who are suspected of COVID-19. This test utilizes a lateral flow immunoassay technology for the qualitative detection of spike and nucleocapsid protein antigens of SARS-CoV-2 in individuals with known or suspected COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | SG Diagnostics COVID-19 Antigen Rapid Test Kit | SG Diagnostics COVID-19 Antigen Rapid Test Kit (self-use) |
| DIAGNOSTIC_TEST | Polymerase chain reaction (PCR) test | Professional collection of a second swab sample, for confirmation by PCR |
Timeline
- Start date
- 2021-05-11
- Primary completion
- 2021-06-30
- Completion
- 2021-07-10
- First posted
- 2021-05-17
- Last updated
- 2021-05-17
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT04889365. Inclusion in this directory is not an endorsement.